Monod Bio

BiotechnologySeedSeattle, USmonod.bio

Latest round

Seed

Last raised

Jun 2022

Total raised

$24M

Investors

7

About Monod Bio

Based in Washington, US, and founded in 2021 by COO David Shoultz, CSO Alfredo Quijano Rubio, David Baker, Andy (Hsien-Wei) Yeh, and Dave Johnson, Monod Bio, Inc. is a biotechnology company and a spin-off of the University of Washington’s Institute for Protein Design. The company develops biosensors that can detect antibodies, toxins, viral proteins, and other molecules.In October 2025, Monod Bio, Inc. As of March 2022, Daniel-Adriano Silva is the CEO of Monod Bio, Inc. Monod Bio, Inc. develops de novo protein biosensors that emit light when detecting targets, such as antibodies, toxins, viral proteins, and other molecules. Monod Bio, Inc. also plans to hire protein biochemists and engineers, build its own space in Seattle, and increase its employee count by around 15 to 20 by the end of 2022.

Who invested in Monod Bio

7 investors across 1 round

See all investors in Monod Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 10, 2022

    Amount

    $24M

    Investors

    Locked

Questions about Monod Bio

Who invested in Monod Bio?

Monod Bio has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Monod Bio raised?

Monod Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Monod Bio last raise money?

Monod Bio's most recent round on record is a Seed, in Jun 2022.

What does Monod Bio do?

Based in Washington, US, and founded in 2021 by COO David Shoultz, CSO Alfredo Quijano Rubio, David Baker, Andy (Hsien-Wei) Yeh, and Dave Johnson, Monod Bio, Inc.

Where is Monod Bio headquartered?

Monod Bio is headquartered in Seattle, US.

Which VCs invest in companies like Monod Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Monod Bio's stage. Their profiles are linked below.

Raising like Monod Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.